The Journal of invasive cardiology
-
Seventy-two patients undergoing interventional procedures were randomized to 3 groups for anesthetic administration just prior to sheath removal. Group 1 (control) received no local anesthetic. Group 2 (local) received 10 ml of lignocaine directly infiltrated with syringe and needle around the sheath. Group 3 (Friend) had the Friend inserted with the sheath and 10 ml of lignocaine was delivered via the device. Pain around the sheath was assessed prior to, during and just after, sheath removal using a 5 point verbal scale. ⋯ The Friend device is a new, inexpensive and safe method of reducing pain associated with removal of arterial sheaths after cardiac interventional procedures.
-
Review Randomized Controlled Trial Comparative Study Clinical Trial
Prophylactic thrombolysis during coronary intervention in unstable angina--results of the TAUSA trial. Thrombolysis and Angioplasty in Unstable Angina Trial.
-
Case Reports Clinical Trial
Radiofrequency catheter ablation as primary therapy for symptomatic ventricular tachycardia.
Most applications of radiofrequency (RF) catheter ablation for treatment of ventricular tachycardia (VT) have been as a treatment of last resort. The purpose of this study was to determine the efficacy and safety of RF catheter ablation as the primary treatment for symptomatic single morphology VT. Eleven of 81 patients (14%) with inducible sustained monomorphic VT underwent RF ablation as the primary treatment. ⋯ There were no serious complications. Patients with VT originating from the left ventricle were offered implantable cardioverter-defibrillator back-up; however, only one patient accepted this option. At a mean follow-up of 12 +/- 7 months, only one patient had a possible arrhythmia recurrence.